Attaching folic acid on gold nanoparticles using noncovalent interaction via different polyethylene glycol backbones and targeting of cancer cells

Resham Bhattacharya, Chitta Ranjan Patra, Alexis Earl, Shanfeng Wang, Aaron Katarya, Lichun Lu, Jayachandran N. Kizhakkedathu, Michael J Yaszemski, Philip R. Greipp, Debabrata Mukhopadhyay, Priyabrata Mukherjee

Research output: Contribution to journalArticle

138 Citations (Scopus)

Abstract

This article reports a simple one-step method of attaching folic acid (FA) to gold nanoparticles (AuNPs) and its fine tuning using different polyethylene glycol (PEG) backbones. PEG backbones used in this study are PEG-diamine with molecular weights 2000 (PAM2-2K) and 10,000 (PAM2-10K), PEG-tetramine with molecular weight 20,000 (PAM4-20K), and PEG-dithiol with molecular weight 2000 (PSH2-2K). The nanoconjugates were characterized with ultraviolet-visible spectroscopy, transmission electron microscopy (TEM), thermogravimetric analysis, Fourier transform infrared spectroscopy, inductively coupled plasma analysis, and radioactivity measurement with a scintillation counter. Attachment and release profiles of FAs from the nanoconjugates are done using 3H-labelled FAs (3FA). The binding of 3FA follows the order Au-PAM4-20K > Au-PAM2-10K > Au-PAM2-2K > Au > Au-PSH2-2K, whereas its release profile follows the reverse order. Au-PAM4-20K-FA has been used for folate receptor (FR)-mediated targeting of AuNPs to cancer cells. Seven different cancer cell lines (SKOV-3, OVCAR-5, OV-202, OV-167, OPM-1, RPMI, and U266) were screened for expression of FRs. Among ovarian cancer cells, the expression pattern of FRs follows the order OV-167 > SKOV-3 > OV-202 > OVCAR-5, and multiple myeloma cell lines follow the order OPM-1 > U266 > RPMI. Intracellular uptakes of the nanoconjugates containing FA or no FA were monitored with digital optical photography and TEM. Quantitation of the internalization of nanoconjugates in different cell lines was determined by gold analysis with inductively coupled plasma. It is found that the uptake of the nanoconjugates correlates with FR expression. Maximum uptake is observed for OV-167, whereas it is minimum for OVCAR-5. TEM images of the cells treated with Au-PAM4-20K-FA confirm the endocytosis of the nanoconjugates. This study is an important step for targeted delivery of anticancer drugs as well as metal nanoparticles for targeted therapy, tumor imaging, and ablation exploiting the overexpression of FRs on cancer cells.

Original languageEnglish (US)
Pages (from-to)224-238
Number of pages15
JournalNanomedicine: Nanotechnology, Biology, and Medicine
Volume3
Issue number3
DOIs
StatePublished - Sep 2007

Fingerprint

Nanoconjugates
Folic Acid
Gold
Nanoparticles
Polyethylene glycols
Cells
Acids
Transmission Electron Microscopy
Neoplasms
Molecular weight
Inductively coupled plasma
tetramethylenedisulfotetramine
Transmission electron microscopy
Molecular Weight
Cell Line
Radioactivity measurement
Scintillation counters
Metal Nanoparticles
Metal nanoparticles
Ultraviolet visible spectroscopy

Keywords

  • Folic acid
  • Gold nanoparticles
  • Multiple myeloma
  • Ovarian cancer
  • Targeting

ASJC Scopus subject areas

  • Molecular Biology
  • Molecular Medicine
  • Biotechnology
  • Biophysics
  • Medicine (miscellaneous)

Cite this

Attaching folic acid on gold nanoparticles using noncovalent interaction via different polyethylene glycol backbones and targeting of cancer cells. / Bhattacharya, Resham; Patra, Chitta Ranjan; Earl, Alexis; Wang, Shanfeng; Katarya, Aaron; Lu, Lichun; Kizhakkedathu, Jayachandran N.; Yaszemski, Michael J; Greipp, Philip R.; Mukhopadhyay, Debabrata; Mukherjee, Priyabrata.

In: Nanomedicine: Nanotechnology, Biology, and Medicine, Vol. 3, No. 3, 09.2007, p. 224-238.

Research output: Contribution to journalArticle

Bhattacharya, Resham ; Patra, Chitta Ranjan ; Earl, Alexis ; Wang, Shanfeng ; Katarya, Aaron ; Lu, Lichun ; Kizhakkedathu, Jayachandran N. ; Yaszemski, Michael J ; Greipp, Philip R. ; Mukhopadhyay, Debabrata ; Mukherjee, Priyabrata. / Attaching folic acid on gold nanoparticles using noncovalent interaction via different polyethylene glycol backbones and targeting of cancer cells. In: Nanomedicine: Nanotechnology, Biology, and Medicine. 2007 ; Vol. 3, No. 3. pp. 224-238.
@article{4ad7666ecd494f3c9fa9a82c8f611402,
title = "Attaching folic acid on gold nanoparticles using noncovalent interaction via different polyethylene glycol backbones and targeting of cancer cells",
abstract = "This article reports a simple one-step method of attaching folic acid (FA) to gold nanoparticles (AuNPs) and its fine tuning using different polyethylene glycol (PEG) backbones. PEG backbones used in this study are PEG-diamine with molecular weights 2000 (PAM2-2K) and 10,000 (PAM2-10K), PEG-tetramine with molecular weight 20,000 (PAM4-20K), and PEG-dithiol with molecular weight 2000 (PSH2-2K). The nanoconjugates were characterized with ultraviolet-visible spectroscopy, transmission electron microscopy (TEM), thermogravimetric analysis, Fourier transform infrared spectroscopy, inductively coupled plasma analysis, and radioactivity measurement with a scintillation counter. Attachment and release profiles of FAs from the nanoconjugates are done using 3H-labelled FAs (3FA). The binding of 3FA follows the order Au-PAM4-20K > Au-PAM2-10K > Au-PAM2-2K > Au > Au-PSH2-2K, whereas its release profile follows the reverse order. Au-PAM4-20K-FA has been used for folate receptor (FR)-mediated targeting of AuNPs to cancer cells. Seven different cancer cell lines (SKOV-3, OVCAR-5, OV-202, OV-167, OPM-1, RPMI, and U266) were screened for expression of FRs. Among ovarian cancer cells, the expression pattern of FRs follows the order OV-167 > SKOV-3 > OV-202 > OVCAR-5, and multiple myeloma cell lines follow the order OPM-1 > U266 > RPMI. Intracellular uptakes of the nanoconjugates containing FA or no FA were monitored with digital optical photography and TEM. Quantitation of the internalization of nanoconjugates in different cell lines was determined by gold analysis with inductively coupled plasma. It is found that the uptake of the nanoconjugates correlates with FR expression. Maximum uptake is observed for OV-167, whereas it is minimum for OVCAR-5. TEM images of the cells treated with Au-PAM4-20K-FA confirm the endocytosis of the nanoconjugates. This study is an important step for targeted delivery of anticancer drugs as well as metal nanoparticles for targeted therapy, tumor imaging, and ablation exploiting the overexpression of FRs on cancer cells.",
keywords = "Folic acid, Gold nanoparticles, Multiple myeloma, Ovarian cancer, Targeting",
author = "Resham Bhattacharya and Patra, {Chitta Ranjan} and Alexis Earl and Shanfeng Wang and Aaron Katarya and Lichun Lu and Kizhakkedathu, {Jayachandran N.} and Yaszemski, {Michael J} and Greipp, {Philip R.} and Debabrata Mukhopadhyay and Priyabrata Mukherjee",
year = "2007",
month = "9",
doi = "10.1016/j.nano.2007.07.001",
language = "English (US)",
volume = "3",
pages = "224--238",
journal = "Nanomedicine: Nanotechnology, Biology, and Medicine",
issn = "1549-9634",
publisher = "Elsevier Inc.",
number = "3",

}

TY - JOUR

T1 - Attaching folic acid on gold nanoparticles using noncovalent interaction via different polyethylene glycol backbones and targeting of cancer cells

AU - Bhattacharya, Resham

AU - Patra, Chitta Ranjan

AU - Earl, Alexis

AU - Wang, Shanfeng

AU - Katarya, Aaron

AU - Lu, Lichun

AU - Kizhakkedathu, Jayachandran N.

AU - Yaszemski, Michael J

AU - Greipp, Philip R.

AU - Mukhopadhyay, Debabrata

AU - Mukherjee, Priyabrata

PY - 2007/9

Y1 - 2007/9

N2 - This article reports a simple one-step method of attaching folic acid (FA) to gold nanoparticles (AuNPs) and its fine tuning using different polyethylene glycol (PEG) backbones. PEG backbones used in this study are PEG-diamine with molecular weights 2000 (PAM2-2K) and 10,000 (PAM2-10K), PEG-tetramine with molecular weight 20,000 (PAM4-20K), and PEG-dithiol with molecular weight 2000 (PSH2-2K). The nanoconjugates were characterized with ultraviolet-visible spectroscopy, transmission electron microscopy (TEM), thermogravimetric analysis, Fourier transform infrared spectroscopy, inductively coupled plasma analysis, and radioactivity measurement with a scintillation counter. Attachment and release profiles of FAs from the nanoconjugates are done using 3H-labelled FAs (3FA). The binding of 3FA follows the order Au-PAM4-20K > Au-PAM2-10K > Au-PAM2-2K > Au > Au-PSH2-2K, whereas its release profile follows the reverse order. Au-PAM4-20K-FA has been used for folate receptor (FR)-mediated targeting of AuNPs to cancer cells. Seven different cancer cell lines (SKOV-3, OVCAR-5, OV-202, OV-167, OPM-1, RPMI, and U266) were screened for expression of FRs. Among ovarian cancer cells, the expression pattern of FRs follows the order OV-167 > SKOV-3 > OV-202 > OVCAR-5, and multiple myeloma cell lines follow the order OPM-1 > U266 > RPMI. Intracellular uptakes of the nanoconjugates containing FA or no FA were monitored with digital optical photography and TEM. Quantitation of the internalization of nanoconjugates in different cell lines was determined by gold analysis with inductively coupled plasma. It is found that the uptake of the nanoconjugates correlates with FR expression. Maximum uptake is observed for OV-167, whereas it is minimum for OVCAR-5. TEM images of the cells treated with Au-PAM4-20K-FA confirm the endocytosis of the nanoconjugates. This study is an important step for targeted delivery of anticancer drugs as well as metal nanoparticles for targeted therapy, tumor imaging, and ablation exploiting the overexpression of FRs on cancer cells.

AB - This article reports a simple one-step method of attaching folic acid (FA) to gold nanoparticles (AuNPs) and its fine tuning using different polyethylene glycol (PEG) backbones. PEG backbones used in this study are PEG-diamine with molecular weights 2000 (PAM2-2K) and 10,000 (PAM2-10K), PEG-tetramine with molecular weight 20,000 (PAM4-20K), and PEG-dithiol with molecular weight 2000 (PSH2-2K). The nanoconjugates were characterized with ultraviolet-visible spectroscopy, transmission electron microscopy (TEM), thermogravimetric analysis, Fourier transform infrared spectroscopy, inductively coupled plasma analysis, and radioactivity measurement with a scintillation counter. Attachment and release profiles of FAs from the nanoconjugates are done using 3H-labelled FAs (3FA). The binding of 3FA follows the order Au-PAM4-20K > Au-PAM2-10K > Au-PAM2-2K > Au > Au-PSH2-2K, whereas its release profile follows the reverse order. Au-PAM4-20K-FA has been used for folate receptor (FR)-mediated targeting of AuNPs to cancer cells. Seven different cancer cell lines (SKOV-3, OVCAR-5, OV-202, OV-167, OPM-1, RPMI, and U266) were screened for expression of FRs. Among ovarian cancer cells, the expression pattern of FRs follows the order OV-167 > SKOV-3 > OV-202 > OVCAR-5, and multiple myeloma cell lines follow the order OPM-1 > U266 > RPMI. Intracellular uptakes of the nanoconjugates containing FA or no FA were monitored with digital optical photography and TEM. Quantitation of the internalization of nanoconjugates in different cell lines was determined by gold analysis with inductively coupled plasma. It is found that the uptake of the nanoconjugates correlates with FR expression. Maximum uptake is observed for OV-167, whereas it is minimum for OVCAR-5. TEM images of the cells treated with Au-PAM4-20K-FA confirm the endocytosis of the nanoconjugates. This study is an important step for targeted delivery of anticancer drugs as well as metal nanoparticles for targeted therapy, tumor imaging, and ablation exploiting the overexpression of FRs on cancer cells.

KW - Folic acid

KW - Gold nanoparticles

KW - Multiple myeloma

KW - Ovarian cancer

KW - Targeting

UR - http://www.scopus.com/inward/record.url?scp=34548240631&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34548240631&partnerID=8YFLogxK

U2 - 10.1016/j.nano.2007.07.001

DO - 10.1016/j.nano.2007.07.001

M3 - Article

AN - SCOPUS:34548240631

VL - 3

SP - 224

EP - 238

JO - Nanomedicine: Nanotechnology, Biology, and Medicine

JF - Nanomedicine: Nanotechnology, Biology, and Medicine

SN - 1549-9634

IS - 3

ER -